We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-4.69%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
-$972M
Cap. Flow
+$106M
Cap. Flow %
0.72%
Top 10 Hldgs %
23.63%
Holding
875
New
75
Increased
357
Reduced
296
Closed
67

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$90.2M
2
MRK icon
Merck
MRK
+$70M
3
ADBE icon
Adobe
ADBE
+$55.1M
4
BKNG icon
Booking.com
BKNG
+$34.5M
5
NOW icon
ServiceNow
NOW
+$30.3M

Sector Composition

Rank Sector Weight
1 Healthcare 29.35%
2 Technology 26.36%
3 Financials 8.78%
4 Communication Services 7.85%
5 Consumer Discretionary 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPAY
201
DELISTED
Bottomline Technologies Inc
EPAY
$15.2M 0.1%
268,238
+165,658
+161% +$9.37M
BMO icon
202
Bank of Montreal
BMO
$127B
$15.1M 0.1%
128,324
-7,846
-6% -$909K
TRI icon
203
Thomson Reuters
TRI
$45.1B
$15.1M 0.1%
131,542
+62,197
+90% +$6.94M
CRNC icon
204
Cerence
CRNC
$368M
$14.9M 0.1%
413,118
+132,070
+47% +$6.5M
ZBRA icon
205
Zebra Technologies
ZBRA
$13.5B
$14.5M 0.1%
35,064
+10,349
+42% +$4.75M
R icon
206
Ryder
R
$9.98B
$14.2M 0.1%
179,239
+111,385
+164% +$8.66M
VG
207
DELISTED
Vonage Holdings Corporation
VG
$13.8M 0.09%
682,040
+125,764
+23% +$2.57M
GS icon
208
Goldman Sachs
GS
$305B
$13.6M 0.09%
41,300
+38,727
+1,505% +$13.7M
NFLX icon
209
Netflix
NFLX
$301B
$13.6M 0.09%
363,360
+23,580
+7% +$982K
TPTX
210
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$13.5M 0.09%
503,288
-72,200
-13% -$2.43M
HPQ icon
211
HP
HPQ
$25.9B
$13.4M 0.09%
369,868
-267,976
-42% -$9.9M
RHI icon
212
Robert Half
RHI
$4.04B
$13.4M 0.09%
117,373
-146,365
-55% -$16.9M
BDX icon
213
Becton Dickinson
BDX
$45.8B
$13.3M 0.09%
51,250
-13,899
-21% -$3.58M
PCRX icon
214
Pacira BioSciences
PCRX
$1.05B
$13.3M 0.09%
174,081
-56,000
-24% -$3.73M
WFC icon
215
Wells Fargo
WFC
$263B
$13.3M 0.09%
273,936
+770
+0.3% +$41.2K
COGT icon
216
Cogent Biosciences
COGT
$6.95B
$13.1M 0.09%
1,752,980
-112,792
-6% -$785K
CI icon
217
Cigna
CI
$79.6B
$13.1M 0.09%
54,572
-2,269
-4% -$531K
HUM icon
218
Humana
HUM
$46.7B
$13M 0.09%
29,809
+5,964
+25% +$2.49M
ECL icon
219
Ecolab
ECL
$79.6B
$12.9M 0.09%
73,182
+10,676
+17% +$2.01M
UNP icon
220
Union Pacific
UNP
$175B
$12.9M 0.09%
47,144
+1,664
+4% +$420K
HLT icon
221
Hilton Worldwide
HLT
$73.4B
$12.5M 0.09%
82,382
-61,659
-43% -$9.09M
IBM icon
222
IBM
IBM
$214B
$12.4M 0.08%
95,662
+1,821
+2% +$237K
ARWR icon
223
Arrowhead Research
ARWR
$12.1B
$12.4M 0.08%
270,054
+210,867
+356% +$10.4M
DE icon
224
Deere & Co
DE
$173B
$12.3M 0.08%
29,659
-911
-3% -$349K
RLAY icon
225
Relay Therapeutics
RLAY
$3.99B
$12.3M 0.08%
411,416
-118,469
-22% -$2.87M

Similar funds

Candriam SCA's Q1 2022 Portfolio in Review

As of Q1 2022, Candriam SCA held 875 positions worth $14.7B, down 6.2% from $15.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q1 2022 filing shows 75 new, 357 increased, 296 reduced and 67 closed positions. Its largest new stake was Ecopetrol: 1,389,000 shares worth $25.8M. The largest sale was Amgen, an estimated $51.3M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2022 buy was Ecopetrol: 1,389,000 shares worth $25.8M.
  • Candriam SCA added most to Walt Disney in Q1 2022, an estimated $90.2M increase.
  • Candriam SCA's biggest Q1 2022 reduction was Amgen, cutting an estimated $51.3M.
  • Candriam SCA fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $36.4M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.7B portfolio in Q1 2022.
  • Candriam SCA opened 75 new positions and closed 67 in Q1 2022.
  • Candriam SCA's portfolio value fell 6.2% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q1 2022, filed 13 May 2022.